Accurate Education - Sulforaphane for Chronic Pain: A Patient Guide

Nutraceuticals:

Sulforaphane for Chronic Pain: A Patient Guide

Sulforaphane (SFN), a compound derived from broccoli, shows promise in managing chronic pain by reducing inflammation, oxidative stress, and neuroinflammation. Pre-clinical studies indicate it alleviates neuropathic and cancer-induced pain, potentially enhancing morphine’s efficacy.

See:

Sulforaphane (SFN)

Nutraceutical patient Guides:

Key to Links:

Grey text – handout
Red text – another page on this website
Blue text – Journal publication

Definitions and Terms Related to Pain

Sulforaphane for Chronic Pain: A Patient Guide

1. OVERVIEW

Sulforaphane (SFN) is a sulfur-containing compound (isothiocyanate) derived from cruciferous vegetables, with broccoli sprouts being the richest food source.[1][2] It is formed when the precursor compound, glucoraphanin, is hydrolyzed by the enzyme myrosinase, which occurs during chewing, chopping, or digestion.[3][4]

What makes sulforaphane valuable for chronic pain:

Potent activator of the Nrf2 (nuclear factor erythroid 2-related factor 2) pathway, the master regulator of cellular antioxidant defenses[1][5][6]
Reduces inflammatory gene activation, Suppresses NF-κB activation, and pro-inflammatory (cytokine) compounds (TNF-α, IL-1β, IL-6)[1][3][6]
Inhibits NLRP3 inflammasome activation, reducing inflammatory cell death and cytokine release[7]
Reduces microglial activation and neuroinflammation in the central nervous system[8][9][10]
Enhances morphine’s analgesic effects and may restore opioid receptor effectiveness[11][12][13]
Protects cartilage from degradation by inhibiting matrix metalloproteinases and inflammatory mediators[14][15][16]

How Sulforaphane Compares to Conventional Medications:

Unlike NSAIDs, sulforaphane does not cause gastrointestinal ulceration or cardiovascular risks with long-term use.[2][17] However, clinical evidence for pain conditions in humans remains limited, with most data derived from preclinical (animal) studies.

Sulforaphane’s effects are primarily preventive and modulatory rather than providing immediate pain relief. The onset of benefit is slow (weeks to months), and optimal dosing for pain conditions has not been established in human trials.[18][16]

—

2. DIETARY SOURCES

Sulforaphane is not directly present in vegetables but is formed from its precursor glucoraphanin when plant tissue is damaged (chewing, cutting) and myrosinase enzyme is released.[3][4]

High Glucoraphanin/Sulforaphane Sources:

Broccoli sprouts (3-day old): 6.0-6.3 mg/g dry weight sulforaphane – the richest source, containing 10-100 times more glucoraphanin than mature broccoli[19][20][21]
Broccoli seeds: High glucoraphanin content, but sulforaphane content decreases during early germination[19]
Mature broccoli: Lower content than sprouts; varies by cultivar
Kale sprouts: May have higher sulforaphane than some broccoli cultivars[22]
Brussels sprouts, cabbage, cauliflower, radish: Contain glucosinolates but lower glucoraphanin content[3]

Important Bioavailability Notes:

Raw broccoli provides 37% bioavailability vs. only 3.4% from cooked broccoli due to heat inactivation of myrosinase[23]
Boiling and blanching cause the largest losses of glucoraphanin and sulforaphane[4]
Light steaming (1-2 minutes) or short microwaving preserves myrosinase activity better than prolonged cooking[4][24]
Preparations with active myrosinase (raw or lightly cooked) provide 3-4 times greater sulforaphane bioavailability than those without[25]
Gut microbiota can convert glucoraphanin to sulforaphane, but this conversion is less efficient and more variable than plant myrosinase[3][25]
Sulforaphane is rapidly absorbed (peak plasma at 1-3 hours from raw sources, 6 hours from cooked) and rapidly excreted (half-life ~2.5 hours)[23][26]

—

3. INDICATIONS FOR NUTRACEUTICAL SUPPLEMENTATION

Pain Conditions with Preclinical Evidence (Animal Studies):

Inflammatory Pain – MODERATE Preclinical Evidence

Sulforaphane (5-10 mg/kg) inhibited allodynia and hyperalgesia in CFA-induced inflammatory pain models[11]
Reduced inflammatory markers (NOS2, CD11b/c) and MAPK phosphorylation in spinal cord[11]
Enhanced morphine’s local antinociceptive effects[11]

Neuropathic Pain – MODERATE Preclinical Evidence

Reduced nociceptive responses, anxiety, and depressive behaviors in sciatic nerve injury models[12]
Normalized oxidative stress via Nrf2/HO-1 signaling in spinal cord, prefrontal cortex, and hippocampus[12]

Potentiated morphine’s anti-allodynic effects by restoring μ-opioid receptor expression[12]

Chemotherapy-Induced Neuropathy – LOW-MODERATE Preclinical Evidence

Glucoraphanin and sulforaphane reduced oxaliplatin-induced neuropathic pain in mice[27]
Repeated administration prevented development of chemotherapy-induced neuropathy[27]
Effects mediated through H₂S release and Kv7 potassium channel modulation[27]

Fibromyalgia-Like Pain – LOW Preclinical Evidence

Sulforaphane showed dose-dependent antiallodynic and antihyperalgesic effects in rat fibromyalgia model[28]
Combination with gabapentin enhanced effects, potentially allowing dose reduction of both agents[28]

Cancer-Induced Bone Pain – LOW Preclinical Evidence

Intrathecal sulforaphane alleviated hyperalgesia in cancer-induced bone pain model[13]
Enhanced morphine’s analgesic effects by restoring spinal μ-opioid receptor expression[13]

Osteoarthritis – LOW-MODERATE Preclinical Evidence + Early Human Data

Sulforaphane inhibited cartilage degradation in cell and animal OA models[14][15][16]
Blocked prostaglandin and nitric oxide synthesis in human chondrocytes[16]
Proof-of-principle trial: Isothiocyanates detected in human synovial fluid after high-glucosinolate broccoli diet[29]

Rheumatoid Arthritis – LOW Preclinical Evidence

Reduced arthritis scores and histologic inflammation in collagen-induced arthritis mice[6]
Decreased IL-6, IL-17, TNF-α expression and autoantibody production[6]

Note: Human clinical trials specifically for pain conditions are lacking. Most evidence comes from animal models.

—

4. SULFORAPHANE’S IMPACT ON PAIN CONDITIONS

Sulforaphane addresses underlying pathophysiology of chronic pain through multiple mechanisms:

Anti-Inflammatory Actions:

Suppresses NF-κB nuclear translocation, reducing transcription of pro-inflammatory genes[1][3]
Inhibits NLRP3 inflammasome activation, reducing IL-1β and IL-18 secretion[7]
Decreases COX-2 and iNOS expression[11][16]
Reduces pro-inflammatory cytokines (TNF-α, IL-1β, IL-6)[6][30]

Antioxidant Actions (via Nrf2 Activation):

Induces phase II detoxification enzymes (HO-1, NQO1, glutathione S-transferases)[1][5][6]
Increases cellular glutathione levels[1]
Reduces reactive oxygen species production[8][10]

Joint-Protective Effects:

Inhibits matrix metalloproteinases (MMP-2, ADAMTS-5) that degrade cartilage[15][16]
Blocks proteoglycan and type II collagen degradation[16]
Protects chondrocytes from oxidative stress-induced apoptosis via SIRT1 activation[31]

—

5. SULFORAPHANE’S IMPACT ON PAIN PROCESSING

Pain processing refers to how pain signals are processed from the initial damaged tissue source of pain through the nerves and spinal cord to the brain and then down the spinal cord again. Sulforaphane offers potential benefit for reducing the severity of the pain experience by acting at various levels of pain processing.

Level 1: Peripheral Pain Receptor (Nociception Transduction)

Reduces prostaglandin E2 production at sites of tissue injury[16]
Decreases peripheral inflammatory mediators that sensitize nociceptors[11]

Level 2: Primary Afferent Transmission to Spinal Cord

Protects dorsal root ganglion neurons from inflammatory damage[12]
May modulate Kv7 potassium channels involved in pain transmission[27]

Level 3: Spinal Cord Dorsal Horn Processing (First Synapse)

Inhibits spinal cord microglial activation (reduces CD11b/c expression)[11][12]
Reduces spinal cord NOS2 overexpression[11]
Inhibits MAPK (JNK, ERK1/2, p38) phosphorylation in spinal cord[11][12]
Decreases spinal cord inflammatory cytokine production[13]

Level 4: Ascending Spinal Pathways and Supraspinal Processing

Provides neuroprotection through Nrf2-mediated antioxidant mechanisms[8][9]
Reduces neuroinflammation in ascending pain pathways[9]

Level 5: Brain Cortical Processing and Pain Perception

Modulates microglial phenotype toward anti-inflammatory (Mox) state[10]
Reduces anxiety and depressive behaviors associated with chronic pain[12]
Protects against neuroinflammation in prefrontal cortex and hippocampus[12]

Level 6: Descending Pain Modulation

Restores μ-opioid receptor expression in spinal cord and hippocampus[12][13]
Enhances endogenous opioid system function[13]
Reduces central inflammatory processes that impair descending inhibition[12]

—

6. BENEFITS FOR PAIN SENSITIZATION

Peripheral Sensitization: MODERATE Preclinical Evidence

Reduces prostaglandin-mediated sensitization of peripheral nociceptors[11][16]
Decreases inflammatory cytokines at sites of tissue injury[6][30]
Inhibits COX-2 and iNOS expression in peripheral tissues[11][16]

Central Sensitization: MODERATE Preclinical Evidence

Suppresses spinal cord microglial and astrocyte activation[11][12]
Inhibits MAPK signaling pathways (JNK, ERK1/2, p38) in spinal cord[11][12]
Reduces spinal cord cytokine production[13]
Normalizes Nrf2/HO-1 signaling in CNS structures involved in pain processing[12]

—

7. SULFORAPHANE’S IMPACT ON THE 4 DRIVING FORCES OF CHRONIC PAIN

1. Systemic Inflammation: STRONG EFFECT

Potent inhibitor of NF-κB, the master regulator of inflammatory gene expression[1][3]
Reduces pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-17)[6][30]
Inhibits NLRP3 inflammasome activation[7]
Suppresses COX-2 and prostaglandin synthesis[16]

2. Neuroinflammation: STRONG EFFECT

Suppresses microglial activation through Nrf2 pathway[8][9][10]
Shifts microglia toward anti-inflammatory Mox phenotype[10]
Reduces neuroinflammatory cytokine production in CNS[8][9]
Inhibits LPS-induced microglial inflammation[10]
Crosses blood-brain barrier and protects it[21]

3. Oxidative Stress: STRONG EFFECT

Most potent naturally occurring inducer of Nrf2/ARE pathway[1][5][6]
Induces phase II antioxidant enzymes (HO-1, NQO1, glutathione S-transferases)[1][5]
Increases cellular glutathione levels[1]
Reduces reactive oxygen and nitrogen species[10]

4. Mitochondrial Dysfunction: MODERATE EFFECT

Supports mitochondrial function through Nrf2 activation[21]
Protects against mitochondrial oxidative damage[8]
May improve mitochondrial biogenesis[21]

—

8. DOSING, TIMING, DURATION AND ADMINISTRATION

Note: Optimal dosing for pain conditions has not been established in human clinical trials. The following are based on clinical studies for other conditions and preclinical pain research.

Recommended Dosing (Based on Available Human Studies):

Broccoli sprouts (fresh)

Dose: 100-200 g/day
Sulforaphane Equivalent: ~40-100 μmol SFN
Notes: Best bioavailability when raw

Broccoli sprout extract

Dose: 100-400 μmol glucoraphanin/day
Sulforaphane Equivalent: Variable conversion
Notes: Depends on myrosinase activity

Stabilized sulforaphane (SFX-01)

Dose: 300-600 mg/day
Sulforaphane Equivalent: 46-92 mg SFN
Notes: Phase 1 trial dosing |[26]

Standardized supplements

Dose: 10-50 mg sulforaphane/day
Sulforaphane Equivalent: —
Notes: Common commercial doses

Key Dosing Points:

Clinical trials have used wide-ranging doses from 25-800 μmol glucoraphanin equivalents[18][16]
Phase 1 trial of stabilized sulforaphane (SFX-01) showed 300-600 mg/day was well-tolerated over 7 days[26]
Preclinical pain studies used 5-10 mg/kg in mice, which does not directly translate to human dosing[11][12]
Lower doses may be preferable to avoid potential cytotoxic effects seen at higher concentrations[32]

Timing:

Take with meals to reduce gastrointestinal side effects
If using broccoli sprouts, consume raw or lightly steamed to preserve myrosinase
Adding mustard seed powder (contains myrosinase) to cooked broccoli may enhance sulforaphane formation

Duration of Onset:

Nrf2 pathway activation occurs within hours of administration[1]
Clinical benefits for chronic conditions likely require weeks to months of consistent use
Allow minimum 8-12 weeks to assess benefit for chronic pain conditions

—

9. FORMULATION CONSIDERATIONS

Fresh Broccoli Sprouts:

Highest bioavailability when consumed raw[23]
3-day-old sprouts typically have optimal glucoraphanin content[19][20]
Must be chewed thoroughly to release myrosinase
Short shelf life; best grown at home or purchased fresh

Broccoli Sprout Extracts:

Glucoraphanin-rich extracts require gut microbiota for conversion (variable, lower bioavailability)[25]
Extracts with active myrosinase provide 3-4x better bioavailability[25]
Look for products specifying both glucoraphanin content AND myrosinase activity

Stabilized Sulforaphane Products:

Alpha-cyclodextrin complexes (e.g., SFX-01/Sulforadex®) improve stability[26]
Enteric-coated formulations may improve tolerability[26]
More consistent dosing than food sources

Freeze-Dried Broccoli Sprout Powder:

Retains high sulforaphane content (up to 6 mg/g dry weight)[19]
Good stability compared to fresh sprouts
May require addition of myrosinase source for optimal conversion

Quality Considerations:

Choose products with third-party testing for glucoraphanin/sulforaphane content
Verify myrosinase activity if using glucoraphanin-based products
Store supplements in cool, dry conditions away from light
Sulforaphane is inherently unstable; check expiration dates[17][18]

—

10. SYNERGIES WITH OTHER PAIN MEDICATIONS AND NUTRACEUTICALS

Nutraceuticals with Potential Synergy:

Curcumin: Both inhibit NF-κB; complementary anti-inflammatory mechanisms
Omega-3 fatty acids: Both reduce inflammatory cytokines and support Nrf2 pathway
Resveratrol: Both activate SIRT1 pathway; complementary antioxidant effects
Quercetin: Both reduce oxidative stress and inflammation
Alpha-lipoic acid: Complementary antioxidant mechanisms

Conventional Medications:

Morphine/Opioids: Sulforaphane enhanced morphine’s analgesic effects in preclinical studies by restoring μ-opioid receptor expression[11][12][13]
Gabapentin: Preclinical study showed synergistic effects in fibromyalgia model, potentially allowing dose reduction[28]
NSAIDs: Complementary mechanisms; sulforaphane may provide additional anti-inflammatory benefit
Acetaminophen: No known interaction

—

11. DRUG INTERACTIONS

Clinically Significant Interactions:

CYP3A4 Substrates – MONITOR

Sulforaphane inhibits CYP3A4 expression and activity[33]
May increase blood levels of drugs metabolized by CYP3A4 (e.g., many statins, calcium channel blockers, immunosuppressants, some chemotherapy agents)
Clinical significance in humans at dietary doses is uncertain

Anticoagulants (Warfarin) – THEORETICAL CONCERN

Cruciferous vegetables contain vitamin K, which can affect warfarin efficacy
Sulforaphane supplements (without plant material) may have less vitamin K content
Monitor INR if significantly changing cruciferous vegetable intake

Antiepileptic Drugs – USE CAUTION

Sulforaphane increased carbamazepine concentrations in mice (pharmacokinetic interaction)[12]
High doses showed proconvulsant effects in animal seizure models[12]
Use caution in patients with epilepsy; monitor drug levels if applicable

Thyroid Function – MONITOR

Glucosinolates in cruciferous vegetables may affect thyroid function (goitrogenic effect)
Primarily a concern with very high intake and iodine deficiency
Generally not a concern at typical supplement doses

Generally Safe – No Known Significant Interactions:

Gabapentinoids (gabapentin, pregabalin)
Most antidepressants
Proton pump inhibitors
Acetaminophen

—

12. SAFETY AND CONTRAINDICATIONS

Generally Favorable Safety Profile:

Sulforaphane is generally well-tolerated at doses used in clinical trials.[17][18] A Phase 1 trial of stabilized sulforaphane (SFX-01) at 300-600 mg/day for 7 days showed treatment-emergent adverse events in 94% of participants, but these were predominantly mild gastrointestinal symptoms.[26]

Common Side Effects (Generally Mild):

Gastrointestinal discomfort (most common)[26]
Flatulence, bloating
Nausea
Diarrhea
Taste disturbance (sulfurous taste)

Less Common/High-Dose Effects (from animal studies):

Sedation (at very high doses)[12]
Hypothermia (at very high doses)[12]
Motor coordination impairment (at very high doses)[12]

Potential Concerns (from preclinical/bioinformatics data):

Possible skin sensitization potential[34]
Theoretical chromosomal effects at high concentrations[34]
Proconvulsant effects at toxic doses in mice[12]

Contraindications:

Known allergy to cruciferous vegetables or isothiocyanates
Active bleeding disorders (theoretical concern)

Use with Caution:

Patients with epilepsy or seizure disorders[12]
Patients on CYP3A4-metabolized medications[33]
Patients with thyroid disorders (if consuming large amounts of cruciferous vegetables)
Pre-surgical patients – consider stopping 1-2 weeks before surgery (theoretical bleeding concern)

Pregnancy and Lactation:

Cruciferous vegetables are generally considered safe during pregnancy
Insufficient data on concentrated sulforaphane supplements during pregnancy
Consult healthcare provider before using supplements

—

13. SPECIAL CONSIDERATIONS / TIPS

Source matters: Broccoli sprouts contain 10-100 times more glucoraphanin than mature broccoli. Three-day-old sprouts typically have optimal content.[19][20]
Raw is best: Raw broccoli provides ~37% bioavailability vs. only ~3.4% from cooked broccoli due to heat inactivation of myrosinase.[23]
Cooking tips: If cooking broccoli, use light steaming (1-2 minutes) or short microwaving. Adding mustard seed powder after cooking can provide myrosinase to enhance sulforaphane formation.[4]
Chew thoroughly: Myrosinase is released when plant cells are damaged. Thorough chewing of raw broccoli sprouts maximizes sulforaphane formation.[24]
Gut microbiota variability: If using glucoraphanin supplements without myrosinase, conversion depends on gut bacteria and varies significantly between individuals.[25]
Be patient: Benefits for chronic conditions likely require weeks to months of consistent use. Nrf2 pathway effects are cumulative.
Start low: Begin with lower doses and increase gradually to assess tolerance and minimize gastrointestinal side effects.
Growing sprouts: Broccoli sprouts can be easily grown at home in 3-5 days, providing a fresh, economical source.
Storage: Fresh sprouts should be refrigerated and consumed within a few days. Supplements should be stored in cool, dry conditions.
Combination approach: Consider combining with other anti-inflammatory nutraceuticals (omega-3s, curcumin) for potentially synergistic effects.
Evidence limitations: Most pain-specific evidence comes from animal studies. Human clinical trials for chronic pain are needed to confirm efficacy and optimal dosing.

—

14. COSTS

Fresh broccoli sprouts (store-bought): $3-6 per container (approximately 1 week supply)
Home-grown broccoli sprouts (from seeds): $10-20 for seeds lasting several months
Broccoli sprout extract supplements: $15-40 per month
Standardized sulforaphane supplements: $25-60 per month
Stabilized sulforaphane products (pharmaceutical grade): $50-100+ per month

Sulforaphane supplements are available over-the-counter and do not require a prescription. Costs vary significantly by brand, formulation, and sulforaphane content. Growing broccoli sprouts at home is the most economical option for obtaining therapeutic amounts.

—

Remember: Sulforaphane is a promising nutraceutical with strong mechanistic evidence for anti-inflammatory, antioxidant, and neuroprotective effects relevant to chronic pain.

It works primarily through activation of the Nrf2 pathway and inhibition of NF-κB, addressing fundamental drivers of chronic pain including systemic inflammation, neuroinflammation, oxidative stress, and potentially mitochondrial dysfunction.

However, human clinical trials specifically for pain conditions are lacking, and most evidence comes from preclinical (animal) studies. The excellent safety profile at typical doses makes sulforaphane a reasonable adjunctive therapy to consider, but patients should have realistic expectations given the current evidence base.

Benefits are likely to be gradual and modulatory rather than providing immediate pain relief. Always discuss any new supplement with your healthcare provider, especially if you take medications metabolized by CYP3A4 or have a seizure disorder.

Key points to note:

1. Evidence quality differs significantly from omega-3s: While omega-3 fatty acids have multiple human RCTs for pain conditions, sulforaphane’s pain-specific evidence is predominantly preclinical (animal studies). The handout clearly communicates this limitation throughout.

2. Mechanistic strength: Sulforaphane has robust mechanistic evidence for addressing the four driving forces of chronic pain (systemic inflammation, neuroinflammation, oxidative stress, mitochondrial dysfunction), particularly through Nrf2 pathway activation.[1][5][6]

3. Bioavailability considerations: The handout emphasizes the critical importance of myrosinase activity for sulforaphane formation, which significantly impacts how patients should consume or supplement with this compound.[23][25]

4. Safety profile: Generally favorable, though the handout notes potential concerns with high doses and specific populations (epilepsy patients, those on CYP3A4 substrates).[26][33][12]

References

The Integrative Role of Sulforaphane in Preventing Inflammation, Oxidative Stress and Fatigue: A Review of a Potential Protective Phytochemical. Ruhee RT, Suzuki K. Antioxidants (Basel, Switzerland). 2020;9(6):E521. doi:10.3390/antiox9060521.
The Potential Use of L-Sulforaphane for the Treatment of Chronic Inflammatory Diseases: A Review of the Clinical Evidence. Mazarakis N, Snibson K, Licciardi PV, Karagiannis TC. Clinical Nutrition (Edinburgh, Scotland). 2020;39(3):664-675. doi:10.1016/j.clnu.2019.03.022.
Exploring the Anti-Inflammatory Activity of Sulforaphane. Treasure K, Harris J, Williamson G. Immunology and Cell Biology. 2023;101(9):805-828. doi:10.1111/imcb.12686.
Inhibitory Effects of Sulforaphane on NLRP3 Inflammasome Activation. Kiser C, Gonul CP, Olcum M, Genc S. Molecular Immunology. 2021;140:175-185. doi:10.1016/j.molimm.2021.10.014.
The Anti-Arthritis Effect of Sulforaphane, an Activator of Nrf2, Is Associated With Inhibition of Both B Cell Differentiation and the Production of Inflammatory Cytokines. Moon SJ, Jhun J, Ryu J, et al. PloS One. 2021;16(2):e0245986. doi:10.1371/journal.pone.0245986.
Treatment With Sulforaphane Produces Antinociception and Improves Morphine Effects During Inflammatory Pain in Mice. Redondo A, Chamorro PAF, Riego G, Leánez S, Pol O. The Journal of Pharmacology and Experimental Therapeutics. 2017;363(3):293-302. doi:10.1124/jpet.117.244376.
Sulforaphane Inhibited the Nociceptive Responses, Anxiety- And Depressive-Like Behaviors Associated With Neuropathic Pain and Improved the Anti-Allodynic Effects of Morphine in Mice. Ferreira-Chamorro P, Redondo A, Riego G, Leánez S, Pol O. Frontiers in Pharmacology. 2018;9:1332. doi:10.3389/fphar.2018.01332.
Pharmacological Interactions of Sulforaphane and Gabapentin in a Murine Fibromyalgia-Like Pain Model. Zamora-Díaz IY, González-Trujano ME, Martínez-Vargas D, et al. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2025;184:117929. doi:10.1016/j.biopha.2025.117929.
Effect of Glucoraphanin and Sulforaphane Against Chemotherapy-Induced Neuropathic Pain: Kv7 Potassium Channels Modulation by H S Release in Vivo. Lucarini E, Micheli L, Trallori E, et al. Phytotherapy Research : PTR. 2018;32(11):2226-2234. doi:10.1002/ptr.6159.
Anti-Nociceptive and Anti-Inflammatory Effects of Sulforaphane on Sciatic Endometriosis in a Rat Model. Liu Y, Zhang Z, Lu X, et al. Neuroscience Letters. 2020;723:134858. doi:10.1016/j.neulet.2020.134858.
Sulforaphane Alleviates Hyperalgesia and Enhances Analgesic Potency of Morphine in Rats With Cancer-Induced Bone Pain. Fu J, Xu M, Xu L, et al. European Journal of Pharmacology. 2021;909:174412. doi:10.1016/j.ejphar.2021.174412.
The Effect of Processing and Cooking on Glucoraphanin and Sulforaphane in Brassica Vegetables. Sun J, Wang Y, Pang X, et al. Food Chemistry. 2021;360:130007. doi:10.1016/j.foodchem.2021.130007.
Sulforaphane Formation and Bioaccessibility Are More Affected by Steaming Time Than Meal Composition During in Vitro Digestion of Broccoli. Sarvan I, Kramer E, Bouwmeester H, Dekker M, Verkerk R. Food Chemistry. 2017;214:580-586. doi:10.1016/j.foodchem.2016.07.111.
Approaches for Enhancing the Stability and Formation of Sulforaphane. Yuanfeng W, Chengzhi L, Ligen Z, et al. Food Chemistry. 2021;345:128771. doi:10.1016/j.foodchem.2020.128771.
Sulforaphane Bioavailability From Glucoraphanin-Rich Broccoli: Control by Active Endogenous Myrosinase. Fahey JW, Holtzclaw WD, Wehage SL, et al. PloS One. 2015;10(11):e0140963. doi:10.1371/journal.pone.0140963.
Bioactive Sulforaphane From Cruciferous Vegetables: Advances in Biosynthesis, Metabolism, Bioavailability, Delivery, Health Benefits, and Applications. Zhang Y, Zhang W, Zhao Y, et al. Critical Reviews in Food Science and Nutrition. 2025;65(15):3027-3047. doi:10.1080/10408398.2024.2354937.
Bioavailability and Kinetics of Sulforaphane in Humans After Consumption of Cooked Versus Raw Broccoli. Vermeulen M, Klöpping-Ketelaars IW, van den Berg R, Vaes WH. Journal of Agricultural and Food Chemistry. 2008;56(22):10505-9. doi:10.1021/jf801989e.
A Phase 1 Randomized, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Enteric-Coated Stabilized Sulforaphane (SFX-01) in Male Participants. Clack G, Moore C, Ruston L, et al. Advances in Therapy. 2025;42(1):216-232. doi:10.1007/s12325-024-03018-1.
Sulforaphane-a Compound With Potential Health Benefits for Disease Prevention and Treatment: Insights From Pharmacological and Toxicological Experimental Studies. Baralić K, Živanović J, Marić Đ, et al. Antioxidants (Basel, Switzerland). 2024;13(2):147. doi:10.3390/antiox13020147.
Broccoli or Sulforaphane: Is It the Source or Dose That Matters?. Yagishita Y, Fahey JW, Dinkova-Kostova AT, Kensler TW. Molecules (Basel, Switzerland). 2019;24(19):E3593. doi:10.3390/molecules24193593.
Sulforaphane: A Review of Its Therapeutic Potentials, Advances in Its Nanodelivery, Recent Patents, and Clinical Trials. Mangla B, Javed S, Sultan MH, et al. Phytotherapy Research : PTR. 2021;35(10):5440-5458. doi:10.1002/ptr.7176.
KEAP1 and Done? Targeting the NRF2 Pathway With Sulforaphane. Dinkova-Kostova AT, Fahey JW, Kostov RV, Kensler TW. Trends in Food Science & Technology. 2017;69(Pt B):257-269. doi:10.1016/j.tifs.2017.02.002.
Emerging Promise of Sulforaphane-Mediated Nrf2 Signaling Cascade Against Neurological Disorders. Uddin MS, Mamun AA, Jakaria M, et al. The Science of the Total Environment. 2020;707:135624. doi:10.1016/j.scitotenv.2019.135624.
Broccoli for the Brain: A Review of the Neuroprotective Mechanisms of Sulforaphane. Bessetti RN, Litwa KA. Frontiers in Cellular Neuroscience. 2025;19:1601366. doi:10.3389/fncel.2025.1601366.
Sulforaphane’s Multifaceted Potential: From Neuroprotection to Anticancer Action. Otoo RA, Allen AR. Molecules (Basel, Switzerland). 2023;28(19):6902. doi:10.3390/molecules28196902.
Sulforaphane Inhibits Lipopolysaccharide-Induced Inflammation, Cytotoxicity, Oxidative Stress, and miR-155 Expression and Switches to Mox Phenotype Through Activating Extracellular Signal-Regulated Kinase 1/2-Nuclear Factor Erythroid 2-Related Factor 2/Antioxidant Response Element Pathway in Murine Microglial Cells. Eren E, Tufekci KU, Isci KB, et al. Frontiers in Immunology. 2018;9:36. doi:10.3389/fimmu.2018.00036.
Sulforaphane and Brain Health: From Pathways of Action to Effects on Specific Disorders. Fahey JW, Liu H, Batt H, Panjwani AA, Tsuji P. Nutrients. 2025;17(8):1353. doi:10.3390/nu17081353.
Effects of Sulforaphane in the Central Nervous System. Huang C, Wu J, Chen D, et al. European Journal of Pharmacology. 2019;853:153-168. doi:10.1016/j.ejphar.2019.03.010.
Conducting Bioinformatics Analysis to Predict Sulforaphane-Triggered Adverse Outcome Pathways in Healthy Human Cells. Bozic D, Živančević K, Baralić K, et al. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2023;160:114316. doi:10.1016/j.biopha.2023.114316.
Interaction of the Isothiocyanate Sulforaphane With Drug Disposition and Metabolism: Pharmacological and Toxicological Implications. Fimognari C, Lenzi M, Hrelia P. Current Drug Metabolism. 2008;9(7):668-78. doi:10.2174/138920008785821675.
Increased Seizure Susceptibility and Other Toxicity Symptoms Following Acute Sulforaphane Treatment in Mice. Socała K, Nieoczym D, Kowalczuk-Vasilev E, Wyska E, Wlaź P. Toxicology and Applied Pharmacology. 2017;326:43-53. doi:10.1016/j.taap.2017.04.010.
The Dietary Isothiocyanate Sulforaphane Is an Antagonist of the Human Steroid and Xenobiotic Nuclear Receptor. Zhou C, Poulton EJ, Grün F, et al. Molecular Pharmacology. 2007;71(1):220-9. doi:10.1124/mol.106.029264.
Broccoli, Kale, and Radish Sprouts: Key Phytochemical Constituents and DPPH Free Radical Scavenging Activity. Bowen-Forbes C, Armstrong E, Moses A, et al. Molecules (Basel, Switzerland). 2023;28(11):4266. doi:10.3390/molecules28114266.
Physiological and Biochemical Metabolism of Germinating Broccoli Seeds and Sprouts. Gu Y, Guo Q, Zhang L, et al. Journal of Agricultural and Food Chemistry. 2012;60(1):209-13. doi:10.1021/jf203599v.

Emphasis on Education

Accurate Clinic promotes patient education as the foundation of it’s medical care. In Dr. Ehlenberger’s integrative approach to patient care, including conventional and complementary and alternative medical (CAM) treatments, he may encourage or provide advice about the use of supplements. However, the specifics of choice of supplement, dosing and duration of treatment should be individualized through discussion with Dr. Ehlenberger. The following information and reference articles are presented to provide the reader with some of the latest research to facilitate evidence-based, informed decisions regarding the use of conventional as well as CAM treatments.

For medical-legal reasons, access to these links is limited to patients enrolled in an Accurate Clinic medical program.

Should you wish more information regarding any of the subjects listed – or not listed – here, please contact Dr. Ehlenberger. He has literally thousands of published articles to share on hundreds of topics associated with pain management, weight loss, nutrition, addiction recovery and emergency medicine. It would take years for you to read them, as it did him.

For more information, please contact Accurate Clinic.

Supplements recommended by Dr. Ehlenberger may be purchased commercially online

Please read about our statement regarding the sale of products recommended by Dr. Ehlenberger.